{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:36:38Z","timestamp":1792078598714,"version":"4.4.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232197"],"award-info":[{"award-number":["7232197"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972041"],"award-info":[{"award-number":["81972041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023YFC2308000"],"award-info":[{"award-number":["2023YFC2308000"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jaut.2025.103361","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T20:44:52Z","timestamp":1736801092000},"page":"103361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Glycobiology of psoriasis: A review"],"prefix":"10.1016","volume":"151","author":[{"given":"Yinuo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-9109","authenticated-orcid":false,"given":"Hui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2025.103361_bib1","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.jaut.2025.103361_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2025.103361_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2025.103361_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-030-70115-4_10","article-title":"Glycosylation in autoimmune diseases","volume":"1325","author":"Z\u0105bczy\u0144ska","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2025.103361_bib6","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1074\/jbc.M116.715870","article-title":"IL23R (interleukin 23 receptor) variants protective against inflammatory Bowel diseases (IBD) Display loss of function due to Impaired protein stability and intracellular Trafficking","volume":"291","author":"Sivanesan","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib7","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1074\/jbc.M116.723064","article-title":"Structural and functional Attributes of the interleukin-36 receptor","volume":"291","author":"Yi","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jaut.2025.103361_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sbi.2017.04.002","article-title":"Recognition of microbial glycans by soluble human lectins","volume":"44","author":"Wesener","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib10","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1016\/j.csbj.2022.10.019","article-title":"From structure to function - ligand recognition by myeloid C-type lectin receptors","volume":"20","author":"Fischer","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jaut.2025.103361_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41577-018-0004-8","article-title":"C-type lectins in immunity and homeostasis","volume":"18","author":"Brown","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12016-014-8423-1","article-title":"Fucosyltransferase 2: a genetic risk factor for primary Sclerosing Cholangitis and Crohn's disease\u2014a comprehensive review","volume":"48","author":"Maroni","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0009-8981(01)00803-8","article-title":"Fucosylation of \u03b11-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis","volume":"317","author":"Ryd\u00e9n","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2025.103361_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40659-024-00541-x","article-title":"H Antigen expression modulates epidermal Keratinocyte Integrity and differentiation","volume":"57","author":"Jin","year":"2024","journal-title":"Biol. Res."},{"key":"10.1016\/j.jaut.2025.103361_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jid.2020.07.030","article-title":"FUT8 Remodeling of EGFR regulates epidermal keratinocyte proliferation during psoriasis development","volume":"141","author":"Kelel","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1357-2725(99)00116-8","article-title":"Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions","volume":"32","author":"Tumova","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.0022-202X.2004.22316.x","article-title":"Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis","volume":"122","author":"Smetsers","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib18","article-title":"The alterations and roles of glycosaminoglycans in human diseases","volume":"14","author":"Wang","year":"2022","journal-title":"Polymers"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2025.103361_bib19","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1478-6354-13-S1-S4","article-title":"Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future","volume":"13","author":"Schett","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103361_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2746\/0425164054406919","article-title":"Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1","volume":"37","author":"van den Boom","year":"2005","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.jaut.2025.103361_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113148","article-title":"Evaluation of the protective effects of chondroitin sulfate oligosaccharide against osteoarthritis via inactivation of NLRP3 inflammasome by in vivo and in vitro studies","volume":"142","author":"Chang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaut.2025.103361_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214158","article-title":"Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis","volume":"78","author":"Aterido","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103361_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101518","article-title":"Hyaluronic acid: a key Ingredient in the therapy of inflammation","volume":"11","author":"Marinho","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaut.2025.103361_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jaut.2025.103361_bib25","doi-asserted-by":"crossref","first-page":"41046","DOI":"10.1074\/jbc.M109443200","article-title":"Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses","volume":"277","author":"Slevin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1152\/physrev.00052.2009","article-title":"Hyaluronan as an immune regulator in human diseases","volume":"91","author":"Jiang","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jaut.2025.103361_bib27","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1161\/01.ATV.20.6.1480","article-title":"Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats","volume":"20","author":"Chajara","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/rcmb.2005-0386OC","article-title":"Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium","volume":"34","author":"Casalino-Matsuda","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/bm050867v","article-title":"Degradative action of reactive oxygen species on hyaluronan","volume":"7","author":"Solt\u00e9s","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jaut.2025.103361_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/03009742.2019.1577490","article-title":"Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome","volume":"48","author":"Hellman","year":"2019","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103361_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2340\/0001555571232238","article-title":"Histochemical localization of hyaluronan in psoriasis, allergic contact dermatitis and normal skin","volume":"71","author":"Wells","year":"1991","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jaut.2025.103361_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 Assists the Topical anti-psoriatic efficacy of curcumin-Loaded hyaluronan-modified Ethosomes: a new strategy for clustering drug in inflammatory skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jaut.2025.103361_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/glycob\/cws055","article-title":"Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides","volume":"22","author":"Pomin","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaut.2025.103361_bib34","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1021\/ja061906t","article-title":"Discovery of a TNF-alpha antagonist using chondroitin sulfate microarrays","volume":"128","author":"Tully","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jaut.2025.103361_bib35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.sbi.2003.09.011","article-title":"Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate","volume":"13","author":"Sugahara","year":"2003","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib36","doi-asserted-by":"crossref","first-page":"18786","DOI":"10.1074\/jbc.M010053200","article-title":"Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen","volume":"276","author":"Iida","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/416636a","article-title":"Chondroitinase ABC promotes functional recovery after spinal cord injury","volume":"416","author":"Bradbury","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2025.103361_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cbpa.2005.10.003","article-title":"Chemical approaches to deciphering the glycosaminoglycan code","volume":"9","author":"Gama","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-01618-5","article-title":"Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis","volume":"4","author":"Kitazawa","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s42003-020-01618-5","article-title":"Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis","volume":"4","author":"Kitazawa","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/biof.1464","article-title":"Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33","volume":"45","author":"Gross","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.jaut.2025.103361_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2012.12.004","article-title":"Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-\u03baB and STAT3 in human keratinocytes","volume":"70","author":"Andr\u00e9s","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jaut.2025.103361_bib43","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.joca.2010.01.018","article-title":"Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study","volume":"18","author":"M\u00f6ller","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jaut.2025.103361_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5070\/D32ZH8X3VF","article-title":"Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding","volume":"11","author":"Verg\u00e9s","year":"2005","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.jaut.2025.103361_bib45","first-page":"739","article-title":"[Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases]","volume":"123","author":"Verg\u00e9s","year":"2004","journal-title":"Med. Clin."},{"key":"10.1016\/j.jaut.2025.103361_bib46","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2174\/138955706778195180","article-title":"Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities","volume":"6","author":"Ludwig","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gut.47.1.88","article-title":"Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism","volume":"47","author":"Salas","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2025.103361_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fimmu.2020.00483","article-title":"Targeting Chemokine-glycosaminoglycan interactions to inhibit inflammation","volume":"11","author":"Crijns","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312404121","article-title":"A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2","volume":"121","author":"Venegas-Solis","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2025.103361_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/glycob\/cwn114","article-title":"Ganglioside GM3 inhibits VEGF\/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2","volume":"19","author":"Chung","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaut.2025.103361_bib51","first-page":"273","article-title":"Expert consensus on TCM treatment of psoriasis in Dermatology Branch (2017 edition)","volume":"17","author":"Association","year":"2018","journal-title":"China Journal of Integrated Traditional Chinese and Western Medicine Dermatology"},{"key":"10.1016\/j.jaut.2025.103361_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114571","article-title":"Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23\/Th17 cell axis","volume":"281","author":"Song","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jaut.2025.103361_bib53","article-title":"Granatum peel polysaccharides ameliorate imiquimod-induced psoriasis-like dermatitis in mice via suppression of NF-\u03baB and STAT3 pathways","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2025.103361_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135667","article-title":"An inulin-type polysaccharide from Atractylodis Macrocephalae Rhizoma can relieve psoriasis","volume":"280","author":"Tang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jaut.2025.103361_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121963","article-title":"Structural elucidation and anti-psoriasis activity of a novel polysaccharide from Saussurea Costus","volume":"333","author":"Gong","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jaut.2025.103361_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155917","article-title":"Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK\/STAT3 signaling pathway","volume":"133","author":"Lv","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jaut.2025.103361_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbpa.2019.07.005","article-title":"Lectin antagonists in infection, immunity, and inflammation","volume":"53","author":"Meiers","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1517\/13543771003767468","article-title":"Selectin inhibitors: a patent review","volume":"20","author":"Bedard","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jaut.2025.103361_bib59","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/13543784.15.8.963","article-title":"Therapeutic potential of selectin antagonists in psoriasis","volume":"15","author":"Bock","year":"2006","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jaut.2025.103361_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1749-6632.2011.06356.x","article-title":"Sulfated glycans control lymphocyte homing","volume":"1253","author":"Kawashima","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2025.103361_bib61","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.177.7.4742","article-title":"The monoclonal antibody CHO-131 identifies a subset of cutaneous lymphocyte-associated antigen T cells enriched in P-selectin-binding cells","volume":"177","author":"Ni","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clim.2009.07.010","article-title":"Cutaneous lymphocyte-associated antigen (CLA) T cells up-regulate P-selectin ligand expression upon their activation","volume":"133","author":"Ni","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.731911","article-title":"Human CLA(+) memory T cell and cytokines in psoriasis","volume":"8","author":"de Jes\u00fas-Gil","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2025.103361_bib64","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/exd.14113","article-title":"IL\u201015 and IL\u201023 synergize to trigger Th17 response by CLA+ T cells in psoriasis","volume":"29","author":"De Jes\u00fas\u2010Gil","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib65","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jid.2017.08.048","article-title":"Microbe-dependent induction of IL-9 by CLA+ T cells in psoriasis and relationship with IL-17A","volume":"138","author":"Ruiz-Romeu","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib66","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-0625.2010.01095.x","article-title":"Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis","volume":"19","author":"Garbaraviciene","year":"2009","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bjd.12355","article-title":"Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis","volume":"169","author":"Dowlatshahi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib68","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.0906-6705.2004.00177.x","article-title":"Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin","volume":"13","author":"Sigmundsdottir","year":"2004","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bjd.12285","article-title":"Platelet activation: a link between psoriasis per se and subclinical atherosclerosis--a case-control study","volume":"169","author":"Saleh","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib70","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2009.06.053","article-title":"Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin","volume":"62","author":"Tamagawa-Mineoka","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00403-005-0626-0","article-title":"Pan-selectin antagonism improves psoriasis manifestation in mice and man","volume":"297","author":"Friedrich","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jaut.2025.103361_bib72","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/exd.13995","article-title":"Mannan\u2010binding lectin promotes keratinocyte to produce CXCL1 and enhances neutrophil infiltration at the early stages of psoriasis","volume":"28","author":"Zeng","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib73","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1346-8138.16323","article-title":"Mannan\u2010binding lectin exacerbates the severity of psoriasis by promoting plasmacytoid dendritic cell differentiation via the signal transducer and activator of transcription 3\u2013interferon regulatory factor 8 axis","volume":"49","author":"Zeng","year":"2022","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2020.00251","article-title":"C-type lectin-like receptors: Head or Tail in cell Death immunity","volume":"11","author":"Drouin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2014.12.002","article-title":"C-type lectins in immunity: recent developments","volume":"32","author":"Dambuza","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib76","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/JLB.2RI0119-031R","article-title":"Myeloid C\u2010type lectin receptors in skin\/mucoepithelial diseases and tumors","volume":"106","author":"Tang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib77","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ajpath.2016.05.014","article-title":"Reactive oxygen species regulate innate but not Adaptive inflammation in ZAP70-Mutated SKG arthritic mice","volume":"186","author":"Guerard","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2025.103361_bib78","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.20041758","article-title":"A role for fungal \u03b2-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice","volume":"201","author":"Yoshitomi","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103361_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41420-023-01444-8","article-title":"Macrophages mediate psoriasis via Mincle-dependent mechanism in mice","volume":"9","author":"Tan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2025.103361_bib80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2797","article-title":"Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2","volume":"15","author":"Taylor","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2018.00114","article-title":"The macrophage mannose receptor regulate mannan-induced psoriasis, psoriatic arthritis, and rheumatoid arthritis-like disease models","volume":"9","author":"Hagert","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103361_bib82","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.0022-202x.2001.01665.x","article-title":"Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases","volume":"118","author":"Wollenberg","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib83","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/jid.2010.196","article-title":"A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: Upregulation of dectin-1 in psoriasis","volume":"130","author":"de Koning","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib84","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.chom.2009.02.006","article-title":"The macrophage mannose receptor induces IL-17 in response to Candida albicans","volume":"5","author":"Van De Veerdonk","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaut.2025.103361_bib85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s42003-022-03376-y","article-title":"Variants of beta-glucan polysaccharides downregulate autoimmune inflammation","volume":"5","author":"Fahlquist-Hagert","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jaut.2025.103361_bib86","first-page":"10723","volume":"vol. 110","author":"Wohn","year":"2013"},{"key":"10.1016\/j.jaut.2025.103361_bib87","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/IAI.01293-13","article-title":"Immunomodulatory glycan Lacto-N-Fucopentaose III requires Clathrin-mediated Endocytosis to induce alternative activation of antigen-Presenting cells","volume":"82","author":"Srivastava","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jaut.2025.103361_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.3996","article-title":"Psoriasis in humans is associated with down-regulation of galectins in dendritic cells","volume":"228","author":"De La Fuente","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.jaut.2025.103361_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/biom13101472","article-title":"Evaluation of plasma concentrations of galectins-1, 2 and 12 in psoriasis and their clinical Implications","volume":"13","author":"Nowowiejska","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaut.2025.103361_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010341","article-title":"Galectin-2 in health and diseases","volume":"24","author":"Negedu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2025.103361_bib91","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/biology11010088","article-title":"Galectin-3 as a novel Multifaceted and not only cardiovascular biomarker in patients with psoriasis with regard to systemic treatment\u2014Preliminary data","volume":"11","author":"Baran","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.jaut.2025.103361_bib92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jdv.15211","article-title":"Role of galectin\u20103 in subclinical myocardial impairment in psoriasis","volume":"33","author":"Kotwica","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2025.103361_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2011.07.008","article-title":"Galectin-3 and the skin","volume":"64","author":"Larsen","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2025.103361_bib94","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2017.11.002","article-title":"Decrease of galectin-3 in keratinocytes: a potential diagnostic marker and a critical contributor to the pathogenesis of psoriasis","volume":"89","author":"Shi","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2025.103361_bib95","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/exd.13512","article-title":"The expression and function of galectins in skin physiology and pathology","volume":"27","author":"Wu","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib96","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jaad.2017.05.055","article-title":"A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis","volume":"77","author":"Ritchie","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib97","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/08923973.2023.2229510","article-title":"TNF-\u03b1 promotes CXCL-1\/8 production in keratinocytes by downregulating galectin-3 through NF-\u03baB and hsa-miR-27a-3p pathway to contribute psoriasis development","volume":"45","author":"Qiu","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.jaut.2025.103361_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/JCI130740","article-title":"Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2025.103361_bib99","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jid.2020.07.021","article-title":"Galectin-8 is Upregulated in keratinocytes by IL-17A and promotes proliferation by regulating mitosis in psoriasis","volume":"141","author":"Lo","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2025.103361_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313060","article-title":"Glycosylation pattern of serum clusterin in psoriatic arthritis and rheumatoid arthritis-the Search for new diagnostic Glycomarkers","volume":"25","author":"Kratz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2025.103361_bib102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tan.12900","article-title":"Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen","volume":"88","author":"Fu","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.jaut.2025.103361_bib103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1699-0463.1990.tb01025.x","article-title":"Cell surface glycosylation patterns in psoriasis","volume":"98","author":"Dabelsteen","year":"1990","journal-title":"Apmis"},{"key":"10.1016\/j.jaut.2025.103361_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23711","article-title":"Serum N-glycan profiling as a diagnostic biomarker for the identification and assessment of psoriasis","volume":"35","author":"Zou","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jaut.2025.103361_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2022.03.030","article-title":"The psoriasis Glycome: differential expression of Cholesterol Particle glycans and IgA glycans linked to disease severity","author":"Maverakis","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib106","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10067-010-1413-7","article-title":"Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis","volume":"29","author":"Chou","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103361_bib107","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/rheumatology\/ket189","article-title":"Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment","volume":"52","author":"Collins","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103361_bib108","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib109","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jaut.2025.103361_bib110","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1373\/clinchem.2016.255828","article-title":"Comparison of the predictive value of GlycA and other biomarkers of inflammation for total Death, incident cardiovascular events, Noncardiovascular and Noncancer inflammatory-related events, and total cancer events","volume":"62","author":"Duprez","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jaut.2025.103361_bib111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2015.11.001","article-title":"GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study","volume":"452","author":"Connelly","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2025.103361_bib112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cels.2015.09.007","article-title":"The biomarker GlycA is associated with chronic inflammation and predicts long-term risk of severe infection","volume":"1","author":"Ritchie","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.jaut.2025.103361_bib113","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.116.309637","article-title":"GlycA is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis","volume":"119","author":"Joshi","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.jaut.2025.103361_bib114","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0961203315617842","article-title":"GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus","volume":"25","author":"Chung","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2025.103361_bib115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-015-0646-x","article-title":"Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis","volume":"17","author":"Ormseth","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103361_bib116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-016-0982-5","article-title":"A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls","volume":"18","author":"Bartlett","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103361_bib117","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007394","article-title":"Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial","volume":"11","author":"Mehta","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jaut.2025.103361_bib118","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jid.2020.01.025","article-title":"A randomized placebo-controlled trial of Secukinumab on Aortic vascular inflammation in moderate-to-severe plaque psoriasis (VIP-S)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib119","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jid.2019.07.679","article-title":"A phase IV, randomized, double-blind, placebo-controlled Crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U trial)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib120","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/rheumatology\/ket189","article-title":"Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment","volume":"52","author":"Collins","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103361_bib121","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jid.2020.07.030","article-title":"FUT8 Remodeling of EGFR regulates epidermal keratinocyte proliferation during psoriasis development","volume":"141","author":"Kelel","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2025.103361_bib122","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.7150\/ijbs.67587","article-title":"The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review","volume":"18","author":"Tizaoui","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jaut.2025.103361_bib123","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/00325481.2019.1643634","article-title":"Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis","volume":"131","author":"Kong","year":"2019","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jaut.2025.103361_bib124","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14606","article-title":"Serum YKL-40 and IL 17 in Psoriasis: Reliability as prognostic markers for disease severity and responsiveness to treatment","volume":"34","author":"Khashaba","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2025.103361_bib125","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9538451","article-title":"Chitinase-3-Like protein 1 (YKL-40) is a new biomarker of inflammation in psoriasis","volume":"2017","author":"Salomon","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2025.103361_bib126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11010-014-2277-y","article-title":"Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?","volume":"400","author":"Erfan","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jaut.2025.103361_bib127","first-page":"225","article-title":"Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation","volume":"21","author":"Triolo","year":"2003","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112500006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112500006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:13:36Z","timestamp":1740413616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112500006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":127,"alternative-id":["S089684112500006X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103361","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycobiology of psoriasis: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103361"}}